KOLs and APPs can be the driving force behind therapeutic success if effectively selected and managed by company stakeholders. Modern research shows that taking a cross-functional approach to engaging these experts is best. Therefore, teams require direction on the optimal approaches for compliant cross-functional engagement.
DGE is proud to invite you to attend its 4th KOL & Advanced Practice Provider Engagement Forum. This year, because YOU demanded it, our agenda incorporates outreach to Nurse Practitioners (NPs) and Physician Assistants (PAs) who are essential for product information in the clinical setting.
Join us April 29-30th in Philadelphia for a unique learning and networking opportunity about your biggest challenges, including:
- Identifying the best expert for specific needs
- Maintaining contact during slow periods
- Engaging KOLs at medical congresses
- Navigating different compliance rule for NPs and PAs
- Building synergy of cross-functional KOL, NP, and PA engagement
- Understanding omnichannel engagement
- Engaging digital opinion leaders (DOLs)
- Leveraging AI effectively
Related Content
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Clinical Trial Innovation: How Healthcare Technology is Evolving
Join us as we discuss how the healthcare landscape is changing in technology and clinical trial innovation, including diversity improvement, leveraging real-world evidence, comparative arms, and decentralized clinical trials.
Keeping pace with the evolving global landscape in vaccine development
Hear from a panel of Life Science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space. What has been COVID-19's impact on drug development and the regulatory landscape? Key factors contributing to Asia Pacific being recognised as the hub for vaccine development and opportunities for biotech's to leverage. Key considerations for pre-clinical and clinical planning to accelerate vaccine development, supporting a robust global strategy.